Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Biomarkers of Beta Cell Loss/Dysfunction in Diabetes

NCT05505669 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT05505669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05505669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Biomarkers of Beta Cell Loss/Dysfunction in Diabetes
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
March 29, 2022
Completion date
June 21, 2029
Enrollment
165 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes